Brain Tumors

Spine Stereotactic Radiosurgery

Survival: Spine Stereotactic Radiosurgery

In 2018, 125 patients were treated with spine stereotactic radiosurgery, which is mainly used to treat malignant and metastatic tumors to the spine. Both the 30- and 180-day survival rates for these patients were 98% (for the first 6 months of 2018).

Spine Stereotactic Radiosurgery: Karnofsky Performance Scale (N = 26)


Functional status, as measured by the Karnofsky Performance Scale, remained stable or improved in 100% of patients after spine stereotactic radiosurgery. Change in status was defined as a change of ≥ 20 points.